Please use this identifier to cite or link to this item:
|Title:||Emerging ceftazidime-avibactam resistance against carbapenem resistant Escherichia coli and Klebsiella pneumoniae in Lebanon||Authors:||Sobh, Ghena M.
El Karaaoui, AbdulKarim M.
Chaar, Mira El
|Affiliations:||Faculty of Health Sciences||Keywords:||Antimicrobial Resistance
CR E. Coli
CR K. Pneumoniae
|Issue Date:||2021||Publisher:||iMedPub Journals||Part of:||The International Arabic Journal of Antimicrobial Agents||Volume:||10||Issue:||2:3||Abstract:||
Introduction: Ceftazidime-avibactam (CZA) has been introduced as
a novel therapy to essentially combat the rising trends of carbapenem
resistant Enterobacteriaceae. In the absence of in vitro data
about the activity of this drug against carbapenem resistant (CR)
Escherichia coli and Klebsiella pneumoniae in Lebanon, this study
Method: A total of 150 isolates, identified using the MALDI-TOF,
encompassing 50 CR E. coli, 60 CR K. pneumoniae, and 10 isolates
each of extended-spectrum Beta-lactamases (ESBLs), and non-CR
multidrug-resistant (MDR) of each species were analyzed. The minimum
inhibitory concentration (MIC) for CZA was determined by
the E-test (Liofilchem, Roseto degliAbruzzi, Italy). In addition, the
disk diffusion (DD) test was used to determine the activity of CZA
and of the antimicrobials routinely used to test for such pathogens.
Results: The CZA activity against the 50 CR E. coli showed an
MIC50 ≥ 256 μg/mL, MIC90 ≥ 256 μg/mL, and an MIC range of
0.023 to ≥ 256 μg/mL, reflecting a susceptibility of 40%. As For
the 60 CR K. pneumoniae isolates, the MIC50 was ≥ 256 μg/mL,
MIC90 ≥ 256 μg/mL, and the MIC range was 0.094 to ≥ 256 μg/
mL, reflecting a susceptibility of 35%. However, uniform CZA susceptibility
(100%) was detected against ESBL and MDR isolates of
both species, being comparable or higher to the routinely used
Conclusion: Although CZA was recently introduced into Lebanon, it
was surprising to note this low activity of CZA against CR E. coli and
CR K. pneumoniae. To explain such findings, it is worth pursuing investigations
related to antimicrobial utilization in clinical practice and
antimicrobial stewardship. Moreover, genotypic determination is needed
to be revealed to help explain the observed phenotypic resistance.
|URI:||https://scholarhub.balamand.edu.lb/handle/uob/5136||DOI:||10.3823/858||Open URL:||Link to full text||Type:||Journal Article|
|Appears in Collections:||Department of Medical Laboratory Sciences|
Show full item record
checked on Aug 17, 2022
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.